These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8142601)

  • 1. Protective effect of natural TNF-binding protein on human TNF-induced toxicity in mice.
    Ythier A; Gascon MP; Juillard P; Vesin C; Wallach D; Grau GE
    Cytokine; 1993 Sep; 5(5):459-62. PubMed ID: 8142601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of human TNF-induced cutaneous Shwartzmann reaction and acute mortality in mice treated with anti-human TNF monoclonal antibodies.
    Grau GE; Vesin C; De Groote D; Delacroix D; Gysler C; Piguet PF; Lambert PH
    Clin Exp Immunol; 1991 Jun; 84(3):411-4. PubMed ID: 2044219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylated recombinant human tumor necrosis factor binding protein-1 reduces mortality, shock, and production of tumor necrosis factor in rabbit Escherichia coli sepsis.
    Porat R; Paddock HN; Schwaitzberg SD; Connolly RJ; Wilkens T; Dasch JR; Gascon MP; Hutchison JS; Ythier A; Wallach D
    Crit Care Med; 1995 Jun; 23(6):1080-9. PubMed ID: 7774220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to soluble human TNF receptor (TNF binding protein) enhance its ability to block TNF toxicity.
    Adolf GR; Frühbeis B
    Cytokine; 1992 May; 4(3):180-4. PubMed ID: 1379835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of recombinant tumor necrosis factor determines its lethality in mice.
    Ameloot P; Takahashi N; Everaerdt B; Hostens J; Eugster HP; Fiers W; Brouckaert P
    Eur J Immunol; 2002 Oct; 32(10):2759-65. PubMed ID: 12355427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary TNF-binding protein (TNF soluble receptor) protects mice against the lethal effect of TNF and endotoxic shock.
    Bertini R; Delgado R; Faggioni R; Gascon MP; Ythier A; Ghezzi P
    Eur Cytokine Netw; 1993; 4(1):39-42. PubMed ID: 8387827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low susceptibility of NC/Nga mice to tumor necrosis factor-alpha-mediated lethality and hepatocellular damage with D-galactosamine sensitization.
    Koide N; Morikawa A; Naiki Y; Tumurkhuu G; Yoshida T; Ikeda H; Yokochi T
    Clin Immunol; 2009 Feb; 130(2):225-32. PubMed ID: 18945641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute inflammatory response to sheep red blood cells in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: the role of proinflammatory cytokines, IL-1 and TNF.
    Moos AB; Baecher-Steppan L; Kerkvliet NI
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):331-5. PubMed ID: 8048078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of soluble P55 tumour-necrosis factor binding fusion protein on the local Shwartzman and Arthus reactions.
    Norman KE; Williams TJ; Feldmann M; Rossi AG
    Br J Pharmacol; 1996 Feb; 117(3):471-478. PubMed ID: 8821536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does high mobility group 1 protein function as a late mediator for LPS- or TNF-induced shock in galactosamine-sensitized mice?
    Hasunuma R; Maruyama H; Takimoto H; Ryll R; Tanaka S; Kumazawa Y
    J Endotoxin Res; 2002; 8(5):391-8. PubMed ID: 12537698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody-based enzyme immunoassay for quantitation of human tumor necrosis factor binding protein I, a soluble fragment of the 60 kDa TNF receptor, in biological fluids.
    Adolf GR; Apfler I
    J Immunol Methods; 1991 Sep; 143(1):127-36. PubMed ID: 1919033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and tissue distribution of human urinary tumor necrosis factor binding protein in mice.
    Gascon MP; Porchet HC; Le Cotonnec JY; Ythier A; Wallach D; Piguet PF; Grau GE
    Drug Metab Dispos; 1992; 20(4):592-5. PubMed ID: 1356740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced susceptibility of nonobese diabetic mice to TNF-alpha and D-galactosamine-mediated hepatocellular apoptosis and lethality.
    Bahjat FR; Dharnidharka VR; Fukuzuka K; Morel L; Crawford JM; Clare-Salzler MJ; Moldawer LL
    J Immunol; 2000 Dec; 165(11):6559-67. PubMed ID: 11086099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of induction of tolerance to tumour necrosis factor (TNF): no involvement of modulators of TNF bioavailability or receptor binding.
    Takahashi N; Brouckaert P; Bemelmans MH; Buurman WA; Fiers W
    Cytokine; 1994 May; 6(3):235-42. PubMed ID: 8054478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase activation during hepatocyte apoptosis induced by tumor necrosis factor-alpha in galactosamine-sensitized mice.
    Osawa Y; Banno Y; Nagaki M; Nozawa Y; Moriwaki H; Nakashima S
    Liver; 2001 Oct; 21(5):309-19. PubMed ID: 11589767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
    Nakama T; Hirono S; Moriuchi A; Hasuike S; Nagata K; Hori T; Ido A; Hayashi K; Tsubouchi H
    Hepatology; 2001 Jun; 33(6):1441-50. PubMed ID: 11391533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.
    Mohler KM; Torrance DS; Smith CA; Goodwin RG; Stremler KE; Fung VP; Madani H; Widmer MB
    J Immunol; 1993 Aug; 151(3):1548-61. PubMed ID: 8393046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lethal hepatic apoptosis mediated by tumor necrosis factor receptor, unlike Fas-mediated apoptosis, requires hepatocyte sensitization in mice.
    Nagaki M; Sugiyama A; Osawa Y; Naiki T; Nakashima S; Nozawa Y; Moriwaki H
    J Hepatol; 1999 Dec; 31(6):997-1005. PubMed ID: 10604572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice.
    Santucci L; Fiorucci S; Chiorean M; Brunori PM; Di Matteo FM; Sidoni A; Migliorati G; Morelli A
    Gastroenterology; 1996 Sep; 111(3):736-44. PubMed ID: 8780580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ornithine and histidine decarboxylase activities in mice sensitized to endotoxin, interleukin-1 or tumour necrosis factor by D-galactosamine.
    Endo Y; Kikuchi T; Nakamura M
    Br J Pharmacol; 1992 Nov; 107(3):888-94. PubMed ID: 1472981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.